Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Stemmatters logo — Provides cost-effective solutions for the development and ma...

Stemmatters

Provides cost-effective solutions for the development and manufacture of biopharmaceuticals and cell-based products.

Founded 2007 Portugal Portugal 32 employees Venture round Biopharma, Biotechnology +2

General Information

Company Name Stemmatters
Founded Year 2007
Location Portugal Portugal
Employees 32
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Stemmatters. To contact Stemmatters, visit stemmatters.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Stemmatters compare?

A PDF of Stemmatters and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Stemmatters soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Stemmatters

Stemmatters provides contract development and manufacturing organisation (CDMO) services for cell and tissue-based therapies and blood-derived biologics. We are a vertically integrated company with resources and competences addressing all product development stages, from exploratory R&D to cGMP production and clinical batch release. Our domain of expertise is Regenerative Medicine and we have the ability to work across a wide range of cells and product types. Stemmatters’ offering is also sustained by an innovative biomaterial product platform supporting formulation of advanced therapies for multiple indications.

No funding data available for Stemmatters yet.

Stemmatters Alternatives & Competitors

View All Alternatives
Stemmatters vs
JOINN Biologics US Inc.
JOINN Biologics US Inc. United States

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...

Series B
73 employees
Biopharma, Biotechnology
Stemmatters vs
Longeveron Inc
Longeveron Inc United States

Cell-Based Therapies

Post-IPO Equity
29 employees
Biotechnology, Health and Wellness
Stemmatters vs
Autolomous
Autolomous United Kingdom

Pragmatic digital solutions for Cell and Gene Therapy Manufacturing

Grant
38 employees
Biotechnology, Health Care
View all alternatives

FAQ About Stemmatters

Provides cost-effective solutions for the development and manufacture of biopharmaceuticals and cell-based products.
Stemmatters was founded in 2007.
Stemmatters is headquartered in Portugal.
Stemmatters operates in Biopharma, Biotechnology, Health Care and Life Sciences.
Stemmatters has approximately 32 employees.
Top alternatives and competitors to Stemmatters include JOINN Biologics US Inc., Longeveron Inc, Autolomous, Applied Biologics LLC, Revatis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stemmatters and JOINN Biologics US Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Stemmatters, https://bouncewatch.com/company/stemmatters, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes